Literature DB >> 19516179

Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.

Aoshuang Zhu1, Takashi Yoneda, Masashi Demura, Shigehiro Karashima, Mikiya Usukura, Masakazu Yamagishi, Yoshiyu Takeda.   

Abstract

BACKGROUND: The (pro)renin receptor exists in the kidney, blood vessels and the heart. (Pro)renin binds to the receptor and induces tissue injuries directly, completely independent of angiotensin II (Ang II). The renal renin-angiotensin-aldosterone system is activated in salt-sensitive hypertensive rats with in-vitro studies showing aldosterone increases angiotensin-converting enzyme (ACE) activity, renin production and angiotensin II type 1 receptor (AT1R) activity. However, the effect of blockade of mineralocorticoid receptor on the renal (pro)renin receptor, angiotensinogen, ACE and AT1R in Dahl salt-sensitive rats is unknown.
METHODS: The following parameters were measured in Dahl salt-sensitive rats and in Dahl salt-resistant rats fed high-salt or low-salt diets and treated for 8 weeks with or without eplerenone (100 mg/kg per day, orally): blood pressure, plasma renin activity, plasma aldosterone concentration, kidney weight and Ang II contents, urinary protein excretion, glomerular injury (assessed by semiquantitative morphometric analysis) and levels of expression in the kidney of (pro)renin receptor protein and messenger RNA (mRNA) for angiotensinogen, ACE and AT1R.
RESULTS: Dahl salt-sensitive rats fed a high-salt diet had increased kidney/body weight (175%) and urinary protein excretion (886%) and decreased plasma renin activity and plasma aldosterone concentration. The rats developed progressive sclerotic and proliferative glomerular changes, concomitant with increased expression of renal (pro)renin receptor protein and mRNA levels of angiotensinogen, ACE and AT1R and kidney Ang II content. Treatment with eplerenone in Dahl salt-sensitive rats was associated with significant improvements in kidney to body weight ratio, urinary protein excretion and renal injury scores and decreased renal (pro)renin receptor protein expression and angiotensinogen and AT1R mRNA levels and kidney Ang II content.
CONCLUSION: A high salt diet increased the renal renin-angiotensin system, whereas blockade of mineralocorticoid receptors attenuated renal injuries by decreasing the activity of tissue renin-angiotensin system in Dahl salt-sensitive rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19516179     DOI: 10.1097/HJH.0b013e328325d861

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Gαi2-protein-mediated signal transduction: central nervous system molecular mechanism countering the development of sodium-dependent hypertension.

Authors:  Richard D Wainford; Casey Y Carmichael; Crissey L Pascale; Jill T Kuwabara
Journal:  Hypertension       Date:  2014-10-13       Impact factor: 10.190

Review 2.  Primary aldosteronism, diagnosis and treatment in Japan.

Authors:  Yoshiyu Takeda; Shigehoro Karashima; Takashi Yoneda
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

3.  Activation of Renal (Pro)Renin Receptor Contributes to High Fructose-Induced Salt Sensitivity.

Authors:  Chuanming Xu; Aihua Lu; Xiaohan Lu; Linlin Zhang; Hui Fang; Li Zhou; Tianxin Yang
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

4.  Role of intrarenal (pro)renin receptor in ischemic acute kidney injury in rats.

Authors:  Masafumi Ono; Yukitoshi Sakao; Takayuki Tsuji; Naro Ohashi; Hideo Yasuda; Akira Nishiyama; Yoshihide Fujigaki; Akihiko Kato
Journal:  Clin Exp Nephrol       Date:  2014-05-10       Impact factor: 2.801

5.  Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.

Authors:  Tengis S Pavlov; Vladislav Levchenko; Paul M O'Connor; Daria V Ilatovskaya; Oleg Palygin; Takefumi Mori; David L Mattson; Andrey Sorokin; Julian H Lombard; Allen W Cowley; Alexander Staruschenko
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

6.  Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.

Authors:  Qiumei Chen; Richard E Sievers; Monika Varga; Sourabh Kharait; Daniel J Haddad; Aaron K Patton; Christopher S Delany; Sarah C Mutka; Joan P Blonder; Gregory P Dubé; Gary J Rosenthal; Matthew L Springer
Journal:  J Appl Physiol (1985)       Date:  2013-01-24

7.  ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.

Authors:  Chuanming Xu; Fei Wang; Yanting Chen; Shiying Xie; Danielle Sng; Bruno Reversade; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

8.  Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.

Authors:  Atsushi Hashimoto; Yoshimichi Takeda; Shigehiro Karashima; Mitsuhiro Kometani; Daisuke Aono; Masashi Demura; Takuya Higashitani; Seigo Konishi; Takashi Yoneda; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2020-05-12       Impact factor: 3.872

9.  Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity.

Authors:  Ademola Adetokunbo Oyagbemi; Olumuyiwa Abiola Adejumobi; Theophilus Aghogho Jarikre; Olumide Samuel Ajani; Ebunoluwa Racheal Asenuga; Idayat Titilayo Gbadamosi; Aduragbenro Deborah A Adedapo; Abimbola Obemisola Aro; Blessing Seun Ogunpolu; Fasilat Oluwakemi Hassan; Olufunke Olubunmi Falayi; Iyanuoluwa Omolola Ogunmiluyi; Temidayo Olutayo Omobowale; Oluwatosin Adetola Arojojoye; Olufunke Eunice Ola-Davies; Adebowale Benard Saba; Adeolu Alex Adedapo; Benjamin Obukowho Emikpe; Matthew Olugbenga Oyeyemi; Sanah Malomile Nkadimeng; Lyndy Joy McGaw; Prudence Ngalula Kayoka-Kabongo; Oluwafemi Omoniyi Oguntibeju; Momoh Audu Yakubu
Journal:  Biol Trace Elem Res       Date:  2021-04-24       Impact factor: 3.738

Review 10.  DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases.

Authors:  Yoshimichi Takeda; Masashi Demura; Takashi Yoneda; Yoshiyu Takeda
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.